Dianthus Therapeutics, Inc. (DNTH)
110.08
-1.02
(-0.92%)
USD |
NASDAQ |
Aug 24, 16:00
110.08
0.00 (0.00%)
After-Hours: 20:00
Dianthus Therapeutics Enterprise Value : 5.203B for Aug. 21, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| August 21, 2026 | 5.203B |
| August 20, 2026 | 5.115B |
| August 19, 2026 | 5.345B |
| August 18, 2026 | 5.446B |
| August 17, 2026 | 5.409B |
| August 14, 2026 | 5.469B |
| August 13, 2026 | 5.120B |
| August 12, 2026 | 5.274B |
| August 11, 2026 | 5.060B |
| August 10, 2026 | 5.241B |
| August 07, 2026 | 5.083B |
| August 06, 2026 | 5.138B |
| August 05, 2026 | 5.279B |
| August 04, 2026 | 5.164B |
| August 03, 2026 | 4.924B |
| July 31, 2026 | 4.974B |
| July 30, 2026 | 5.287B |
| July 29, 2026 | 4.818B |
| July 28, 2026 | 4.683B |
| July 27, 2026 | 4.840B |
| July 24, 2026 | 4.806B |
| July 23, 2026 | 4.857B |
| July 22, 2026 | 4.746B |
| July 21, 2026 | 4.908B |
| July 20, 2026 | 4.649B |
| Date | Value |
|---|---|
| July 17, 2026 | 4.901B |
| July 16, 2026 | 4.339B |
| July 15, 2026 | 4.589B |
| July 14, 2026 | 4.664B |
| July 13, 2026 | 4.520B |
| July 10, 2026 | 4.463B |
| July 09, 2026 | 4.596B |
| July 08, 2026 | 4.489B |
| July 07, 2026 | 4.362B |
| July 06, 2026 | 4.229B |
| July 02, 2026 | 4.284B |
| July 01, 2026 | 4.058B |
| June 30, 2026 | 4.456B |
| June 29, 2026 | 4.113B |
| June 26, 2026 | 4.095B |
| June 25, 2026 | 3.888B |
| June 24, 2026 | 3.846B |
| June 23, 2026 | 3.668B |
| June 22, 2026 | 3.659B |
| June 18, 2026 | 3.393B |
| June 17, 2026 | 3.360B |
| June 16, 2026 | 3.196B |
| June 15, 2026 | 3.394B |
| June 12, 2026 | 3.370B |
| June 11, 2026 | 3.063B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Legend Biotech Corp. | 3.542B |
| Ironwood Pharmaceuticals, Inc. | 1.027B |
| Verastem, Inc. | 571.40M |
| Fortress Biotech, Inc. | -5.708M |
| AbbVie, Inc. | 532.50B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -50.22M |
| Revenue (Quarterly) | 0.761M |
| Total Expenses (Quarterly) | 50.98M |
| EPS Diluted (Quarterly) | -0.8962 |
| Gross Profit Margin (Quarterly) | 85.94% |
| Profit Margin (Quarterly) | -6.60K% |
| Earnings Yield | -3.77% |
| Normalized Earnings Yield | -3.772 |